Showing results (331-340 of 345) with videos related to

Sort By:
Pageof 35
The Journal of Rheumatology|November 17, 2019
Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo StudyTia Sandström, Vappu Rantalaiho, Timo Yli-Kerttula, et al.
Annals of the Rheumatic Diseases|July 4, 2012
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)Marjatta Leirisalo-Repo, Hannu Kautiainen, Leena Laasonen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 3, 2013
Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patientsIlkka Liikanen, Laura Ahtiainen, Mari L M Hirvinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumorsPetri Nokisalmi, Sari Pesonen, Sophie Escutenaire, et al.
BMC Psychology|May 23, 2018
Understanding developmental language disorder - the Helsinki longitudinal SLI study (HelSLI): a study protocolMarja Laasonen, Sini Smolander, Pekka Lahti-Nuuttila, et al.
International Journal of Cancer|June 2, 2011
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumorsSari Pesonen, Iulia Diaconu, Vincenzo Cerullo, et al.
Gene Therapy|March 19, 2010
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumorsS Pesonen, P Nokisalmi, S Escutenaire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2011
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirusVincenzo Cerullo, Iulia Diaconu, Lotta Kangasniemi, et al.
Cancer Research|February 11, 2012
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patientsSari Pesonen, Iulia Diaconu, Lotta Kangasniemi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 21, 2022
High-Quality Graphene Using Boudouard ReactionArtem K Grebenko, Dmitry V Krasnikov, Anton V Bubis, et al.
Pageof 35